Study of risk reducing bilateral salpingo-oophorectomy (RRSO) for japanese BRCA1/2 mutation carriers
Not Applicable
Recruiting
- Conditions
- hereditary breast and ovarian cancer
- Registration Number
- JPRN-UMIN000020648
- Lead Sponsor
- Juntendo University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Female
- Target Recruitment
- 30
Inclusion Criteria
Not provided
Exclusion Criteria
1.Intlerability to RRSO for other disease 2.Women with ovarian or tubal cancer 3.Women with other ovarian disease
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Incidence and mortality rate of the ovarian/fallopian tube/peritoneal cancer on BRCA1/2 mutant carriers performed risk reducing salpingo-oophorectomy every year
- Secondary Outcome Measures
Name Time Method Adverse event related to RRSO